Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014 (2014), Article ID 185150, 9 pages
http://dx.doi.org/10.1155/2014/185150
Review Article

The Pathology of Orthopedic Implant Failure Is Mediated by Innate Immune System Cytokines

1Department of Orthopaedics, University Hospital Essen, University of Duisburg-Essen, Hufelandstraße 55, 45122 Essen, Germany
2Department of Orthopedics, Rush University Medical Center, 1735 W Harrison MC107, Chicago, IL 60612, USA

Received 11 September 2013; Revised 25 March 2014; Accepted 8 April 2014; Published 7 May 2014

Academic Editor: Charles J. Malemud

Copyright © 2014 Stefan Landgraeber et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. M. Wright and S. B. Goodman, Implant Wear in Total Joint Replacement: Clinical and Biologic Issues, Material and Design Considerations, American Academy of Orthopaedic Surgeons, Rosemont, Ill, USA, 2001.
  2. S. Kurtz, K. Ong, E. Lau, F. Mowat, and M. Halpern, “Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030,” Journal of Bone and Joint Surgery—Series A, vol. 89, no. 4, pp. 780–785, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Herberts and H. Malchau, “Long-term registration has improved the quality of hip replacement: a review of the Swedish THR Register comparing 160,000 cases,” Acta Orthopaedica Scandinavica, vol. 71, no. 2, pp. 111–121, 2000. View at Google Scholar · View at Scopus
  4. O. Robertsson, K. Knutson, S. Lewold, and L. Lidgren, “The Swedish Knee Arthroplasty Register 1975–1997: an update with special emphasis on 41,223 knees operated on in 1988–1997,” Acta Orthopaedica Scandinavica, vol. 72, no. 5, pp. 503–513, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Boehler, H. Plenk Jr., and M. Salzer, “Alumina ceramic bearings for hip endoprostheses: the Austrian experiences,” Clinical Orthopaedics and Related Research, no. 379, pp. 85–93, 2000. View at Google Scholar · View at Scopus
  6. S. Santavirta, M. Takagi, E. Gómez-Barrena et al., “Studies of host response to orthopedic implants and biomaterials,” Journal of Long-Term Effects of Medical Implants, vol. 9, no. 1-2, pp. 67–76, 1999. View at Google Scholar · View at Scopus
  7. H.-G. Willert, H. Bertram, and G. Hans Buchhorn, “Osteolysis in alloarthroplasty of the hip: the role of ultra-high molecular weight polyethylene wear particles,” Clinical Orthopaedics and Related Research, no. 258, pp. 95–107, 1990. View at Google Scholar · View at Scopus
  8. E. M. Schwarz, A. P. Lu, J. J. Goater et al., “Tumor necrosis factor-α/nuclear transcription factor-κB signaling in periprosthetic osteolysis,” Journal of Orthopaedic Research, vol. 18, no. 3, pp. 472–480, 2000. View at Google Scholar · View at Scopus
  9. M. J. Silva and L. J. Sandell, “What's new in orthopaedic research,” Journal of Bone and Joint Surgery—Series A, vol. 84, no. 8, pp. 1490–1496, 2002. View at Google Scholar · View at Scopus
  10. J. T. Wang, “The role of particulate orthopaedic implant materials in peri-implant osteolysis,” in Biological, Material, and Mechanical Considerations of Joint Replacement, B. F. Morrey, Ed., pp. 1–122, Raven Press, New York, NY, USA, 1993. View at Google Scholar
  11. A. J. Rao, E. Gibon, T. Ma, Z. Yao, R. L. Smith, and S. B. Goodman, “Revision joint replacement, wear particles, and macrophage polarization,” Acta Biomaterialia, vol. 8, no. 7, pp. 2815–2823, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Kadoya, P. A. Revell, A. Kobayashi, N. Al-Saffar, G. Scott, and M. A. R. Freeman, “Wear particulate species and bone loss in failed total joint arthroplasties,” Clinical Orthopaedics and Related Research, no. 340, pp. 118–129, 1997. View at Google Scholar · View at Scopus
  13. A. S. Shanbhag, J. J. Jacobs, J. Black, J. O. Galante, and T. T. Glant, “Macrophage/particle interactions: effect of size, composition and surface area,” Journal of Biomedical Materials Research, vol. 28, no. 1, pp. 81–90, 1994. View at Publisher · View at Google Scholar · View at Scopus
  14. P. A. Revell, “Biological causes of prosthesis joint failure,” in Joint Replacement Technology, P. A. Revell, Ed., pp. 349–396, Woodhead Publishing Limited and CRC Press LLC, Cambridge, UK, 2008. View at Google Scholar
  15. M. Lind, M. C. D. Trindade, D. J. Schurman, S. B. Goodman, and R. L. Smith, “Monocyte migration inhibitory factor synthesis and gene expression in particle-activated macrophages,” Cytokine, vol. 12, no. 7, pp. 909–913, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Nakashima, D.-H. Sun, M. C. D. Trindade et al., “Induction of macrophage C-C chemokine expression by titanium alloy and bone cement particles,” Journal of Bone and Joint Surgery - Series B, vol. 81, no. 1, pp. 155–162, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. B. Yaszay, M. C. D. Trindade, M. Lind, S. B. Goodman, and R. L. Smith, “Fibroblast expression of C-C chemokines in response to orthopaedic biomaterial particle challenge in vitro,” Journal of Orthopaedic Research, vol. 19, no. 5, pp. 970–976, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. P.-G. Ren, Z. Huang, T. Ma, S. Biswal, R. L. Smith, and S. B. Goodman, “Surveillance of systemic trafficking of macrophages induced by UHMWPE particles in nude mice by noninvasive imaging,” Journal of Biomedical Materials Research—Part A, vol. 94, no. 3, pp. 706–711, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. P.-G. Ren, A. Irani, Z. Huang, T. Ma, S. Biswal, and S. B. Goodman, “Continuous infusion of UHMWPE particles induces increased bone macrophages and osteolysis,” Clinical Orthopaedics and Related Research, vol. 469, no. 1, pp. 113–122, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. Q. Gu, Q. Shi, and H. Yang, “The role of TLR and chemokine in wear particle-induced aseptic loosening,” Journal of Biomedicine and Biotechnology, vol. 2012, Article ID 596870, 9 pages, 2012. View at Publisher · View at Google Scholar
  21. H. Haleem-Smith, E. Argintar, C. Bush et al., “Biological responses of human mesenchymal stem cells to titanium wear debris particles,” Journal of Orthopaedic Research, vol. 30, no. 6, pp. 853–863, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. A. M. Kaufman, C. I. Alabre, H. E. Rubash, and A. S. Shanbhag, “Human macrophage response to UHMWPE, TiAlV, CoCr, and alumina particles: analysis of multiple cytokines using protein arrays,” Journal of Biomedical Materials Research—Part A, vol. 84, no. 2, pp. 464–474, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. E. Gibon, T. Ma, P.-G. Ren et al., “Selective inhibition of the MCP-1-CCR2 ligand-receptor axis decreases systemic trafficking of macrophages in the presence of UHMWPE particles,” Journal of Orthopaedic Research, vol. 30, no. 4, pp. 547–553, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. Z. Huang, T. Ma, P.-G. Ren, R. L. Smith, and S. B. Goodman, “Effects of orthopedic polymer particles on chemotaxis of macrophages and mesenchymal stem cells,” Journal of Biomedical Materials Research—Part A, vol. 94, no. 4, pp. 1264–1269, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Cadosch, O. P. Gautschi, E. Chan, H.-P. Simmen, and L. Filgueira, “Titanium induced production of chemokines CCL17/TARC and CCL22/MDC in human osteoclasts and osteoblasts,” Journal of Biomedical Materials Research—Part A, vol. 92, no. 2, pp. 475–483, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. E. Gibon, Z. Yao, A. J. Rao et al., “Effect of a CCR1 receptor antagonist on systemic trafficking of MSCs and polyethylene particle-associated bone loss,” Biomaterials, vol. 33, no. 14, pp. 3632–3638, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Leibbrandt and J. M. Penninger, “RANK(L) as a key target for controlling bone loss,” Advances in Experimental Medicine and Biology, vol. 647, pp. 130–145, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Leibbrandt and J. M. Penninger, “RANKL/RANK as key factors for osteoclast development and bone loss in arthropathies,” Advances in Experimental Medicine and Biology, vol. 649, pp. 100–113, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Kadoya, N. Al-Saffar, A. Kobayashi, and P. A. Revell, “The expression of osteoclast markers on foreign body giant cells,” Bone and Mineral, vol. 27, no. 2, pp. 85–96, 1994. View at Google Scholar · View at Scopus
  30. N. A. Athanasou, J. Quinn, and C. J. K. Bulstrode, “Resorption of bone by inflammatory cells derived from the joint capsule of hip arthroplasties,” Journal of Bone and Joint Surgery—Series B, vol. 74, no. 1, pp. 57–62, 1992. View at Google Scholar · View at Scopus
  31. W. Wang, D. J. Ferguson, J. M. Quinn, A. H. Simpson, and N. A. Athanasou, “Osteoclasts are capable of particle phagocytosis and bone resorption,” The Journal of Pathology, vol. 182, no. 1, pp. 92–98, 1997. View at Google Scholar
  32. W. Wang, D. J. P. Ferguson, J. M. W. Quinn, A. H. R. W. Simpson, and N. A. Athanasou, “Biomaterial particle phagocytosis by bone-resorbing osteoclasts,” Journal of Bone and Joint Surgery—Series B, vol. 79, no. 5, pp. 849–856, 1997. View at Publisher · View at Google Scholar · View at Scopus
  33. D. P. Pioletti and A. Kottelat, “The influence of wear particles in the expression of osteoclastogenesis factors by osteoblasts,” Biomaterials, vol. 25, no. 27, pp. 5803–5808, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. K. Lochner, A. Fritsche, A. Jonitz et al., “The potential role of human osteoblasts for periprosthetic osteolysis following exposure to wear particles,” International Journal of Molecular Medicine, vol. 28, no. 6, pp. 1055–1063, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. T. Koreny, M. Tunyogi-Csapó, I. Gál, C. Vermes, J. J. Jacobs, and T. T. Glant, “The role of fibroblasts and fibroblast-derived factors in periprosthetic osteolysis,” Arthritis and Rheumatism, vol. 54, no. 10, pp. 3221–3232, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. N. Al-Saffar and P. A. Revell, “Pathology of the bone-implant interfaces,” Journal of Long-Term Effects of Medical Implants, vol. 9, no. 4, pp. 319–347, 1999. View at Google Scholar · View at Scopus
  37. P. A. Revell, N. Al-Saffar, and A. Kobayashi, “Biological reaction to debris in relation to joint prostheses,” Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine, vol. 211, no. 2, pp. 187–197, 1997. View at Google Scholar · View at Scopus
  38. P. A. Revell, “The combined role of wear particles, macrophages and lymphocytes in the loosening of total joint prostheses,” Journal of the Royal Society Interface, vol. 5, no. 28, pp. 1263–1278, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. B. Hercus, S. Saeed, and P. A. Revell, “Expression profile of T cell associated molecules in the interfacial tissue of aseptically loosened prosthetic joints,” Journal of Materials Science: Materials in Medicine, vol. 13, no. 12, pp. 1153–1156, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. N. J. Hallab, M. Caicedo, A. Finnegan, and J. J. Jacobs, “Th1 type lymphocyte reactivity to metals in patients with total hip arthroplasty,” Journal of Orthopaedic Surgery and Research, vol. 3, no. 1, article 6, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. T.-F. Li, S. Santavirta, V. Waris et al., “No lymphokines in T-cells around loosened hip prostheses,” Acta Orthopaedica Scandinavica, vol. 72, no. 3, pp. 241–247, 2001. View at Publisher · View at Google Scholar · View at Scopus
  42. B. Hercus and P. A. Revell, “Phenotypic characteristics of T lymphocytes in the interfacial tissue of aseptically loosened prosthetic joints,” Journal of Materials Science: Materials in Medicine, vol. 12, no. 10–12, pp. 1063–1067, 2001. View at Publisher · View at Google Scholar · View at Scopus
  43. P. A. Revell and S. E. Jellie, “Interleukin 15 production by macrophages in the implant interface membrane of aseptically loosened joint replacements,” Journal of Materials Science: Materials in Medicine, vol. 9, no. 12, pp. 727–730, 1998. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Saeed and P. A. Revell, “Production and distribution of interleukin 15 and its receptors (IL-15Rα and IL-R2β) in the implant interface tissues obtained during revision of failed total joint replacement,” International Journal of Experimental Pathology, vol. 82, no. 3, pp. 201–209, 2001. View at Publisher · View at Google Scholar · View at Scopus
  45. T. Lähdeoja, J. Pajarinen, V.-P. Kouri, T. Sillat, J. Salo, and Y. T. Konttinen, “TOll-like receptors and aseptic loosening of hip endoprosthesis—a potential to respond against danger signals?” Journal of Orthopaedic Research, vol. 28, no. 2, pp. 184–190, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Pajarinen, E. Cenni, L. Savarino et al., “Profile of toll-like receptor-positive cells in septic and aseptic loosening of total hip arthroplasty implants,” Journal of Biomedical Materials Research—Part A, vol. 94, no. 1, pp. 84–92, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Takagi, Y. Tamaki, H. Hasegawa et al., “Toll-like receptors in the interface membrane around loosening total hip replacement implants,” Journal of Biomedical Materials Research—Part A, vol. 81, no. 4, pp. 1017–1026, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. J. I. Pearl, T. Ma, A. R. Irani et al., “Role of the Toll-like receptor pathway in the recognition of orthopedic implant wear-debris particles,” Biomaterials, vol. 32, no. 24, pp. 5535–5542, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. R. Maitra, C. C. Clement, B. Scharf et al., “Endosomal damage and TLR2 mediated inflammasome activation by alkane particles in the generation of aseptic osteolysis,” Molecular Immunology, vol. 47, no. 2-3, pp. 175–184, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. I. Catelas, A. Petit, D. J. Zukor, R. Marchand, L. Yahia, and O. L. Huk, “Induction of macrophage apoptosis by ceramic and polyethylene particles in vitro,” Biomaterials, vol. 20, no. 7, pp. 625–630, 1999. View at Publisher · View at Google Scholar · View at Scopus
  51. D. Granchi, E. Cenni, G. Ciapetti et al., “CEll death induced by metal ions: necrosis or apoptosis?” Journal of Materials Science: Materials in Medicine, vol. 9, no. 1, pp. 31–37, 1998. View at Publisher · View at Google Scholar · View at Scopus
  52. L. Samelko, M. S. Caicedo, S. J. Lim, C. Della-Valle, J. Jacobs, and N. J. Hallab, “Cobalt-alloy implant debris induce HIF-1alpha hypoxia associated responses: a mechanism for metal-specific orthopedic implant failure,” PLoS One, vol. 8, no. 6, article e67127, 2013. View at Google Scholar
  53. O. L. Huk, D. J. Zukor, W. Ralston, A. Lisbona, and A. Petit, “Apoptosis in interface membranes of aseptically loose total hip arthroplasty,” Journal of Materials Science: Materials in Medicine, vol. 12, no. 7, pp. 653–658, 2001. View at Publisher · View at Google Scholar · View at Scopus
  54. M. L. Wang, R. Tuli, P. A. Manner, P. F. Sharkey, D. J. Hall, and R. S. Tuan, “Direct and indirect induction of apoptosis in human mesenchymal stem cells in response to titanium particles,” Journal of Orthopaedic Research, vol. 21, no. 4, pp. 697–707, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. S. Landgraeber, M. Toetsch, C. Wedemeyer et al., “Over-expression of p53/BAK in aseptic loosening after total hip replacement,” Biomaterials, vol. 27, no. 15, pp. 3010–3020, 2006. View at Publisher · View at Google Scholar · View at Scopus
  56. S. Landgraeber, M. von Knoch, F. Löer et al., “Extrinsic and intrinsic pathways of apoptosis in aseptic loosening after total hip replacement,” Biomaterials, vol. 29, no. 24-25, pp. 3444–3450, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. S. Landgraeber, S. Jaeckel, F. Löer et al., “Pan-caspase inhibition suppresses polyethylene particle-induced osteolysis,” Apoptosis, vol. 14, no. 2, pp. 173–181, 2009. View at Publisher · View at Google Scholar · View at Scopus
  58. C. Cerri, D. Chimenti, I. Conti, T. Neri, P. Paggiaro, and A. Celi, “Monocyte/macrophage-derived microparticles up-regulate inflammatory mediator synthesis by human airway epithelial cells,” Journal of Immunology, vol. 177, no. 3, pp. 1975–1980, 2006. View at Google Scholar · View at Scopus
  59. P. Heyder, I. Bekeredjian-Ding, M. Parcina et al., “Purified apoptotic bodies stimulate plasmacytoid dendritic cells to produce IFN-alpha,” Autoimmunity, vol. 40, no. 4, pp. 331–332, 2007. View at Publisher · View at Google Scholar · View at Scopus
  60. F. Martinon, V. Pétrilli, A. Mayor, A. Tardivel, and J. Tschopp, “Gout-associated uric acid crystals activate the NALP3 inflammasome,” Nature, vol. 440, no. 7081, pp. 237–241, 2006. View at Publisher · View at Google Scholar · View at Scopus
  61. R. Medzhitov, “Origin and physiological roles of inflammation,” Nature, vol. 454, no. 7203, pp. 428–435, 2008. View at Publisher · View at Google Scholar · View at Scopus
  62. J. P.-Y. Ting, S. B. Willingham, and D. T. Bergstralh, “NLRs at the intersection of cell death and immunity,” Nature Reviews Immunology, vol. 8, no. 5, pp. 372–379, 2008. View at Publisher · View at Google Scholar · View at Scopus
  63. C. Dostert, V. Pétrilli, R. Van Bruggen, C. Steele, B. T. Mossman, and J. Tschopp, “Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica,” Science, vol. 320, no. 5876, pp. 674–677, 2008. View at Publisher · View at Google Scholar · View at Scopus
  64. V. Hornung, F. Bauernfeind, A. Halle et al., “Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization,” Nature Immunology, vol. 9, no. 8, pp. 847–856, 2008. View at Publisher · View at Google Scholar · View at Scopus
  65. M. S. Caicedo, R. Desai, K. McAllister, A. Reddy, J. J. Jacobs, and N. J. Hallab, “Soluble and particulate Co-Cr-Mo alloy implant metals activate the inflammasome danger signaling pathway in human macrophages: a novel mechanism for implant debris reactivity,” Journal of Orthopaedic Research, vol. 27, no. 7, pp. 847–854, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. V. Pétrilli, C. Dostert, D. A. Muruve, and J. Tschopp, “The inflammasome: a danger sensing complex triggering innate immunity,” Current Opinion in Immunology, vol. 19, no. 6, pp. 615–622, 2007. View at Publisher · View at Google Scholar · View at Scopus
  67. S. Mariathasan and D. M. Monack, “Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation,” Nature Reviews Immunology, vol. 7, no. 1, pp. 31–40, 2007. View at Publisher · View at Google Scholar · View at Scopus
  68. L. Burton, D. Paget, N. B. Binder et al., “Orthopedic wear debris mediated inflammatory osteolysis is mediated in part by NALP3 inflammasome activation,” Journal of Orthopaedic Research, vol. 31, no. 1, pp. 73–80, 2013. View at Google Scholar
  69. F. Zhou, J. Lu, X. Zhu et al., “Effects of a cannabinoid receptor 2 selective antagonist on the inflammatory reaction to titanium particles in vivo and in vitro,” Journal of International Medical Research, vol. 38, no. 6, pp. 2023–2032, 2010. View at Google Scholar · View at Scopus
  70. J. B. Huang, Y. Ding, D. S. Huang et al., “Inhibition of the PI3K/AKT pathway reduces tumor necrosis factor-alpha production in the cellular response to wear particles in vitro,” Artificial Organs, vol. 37, no. 3, pp. 298–307, 2013. View at Google Scholar
  71. D. Chen, X. Zhang, Y. Guo et al., “MMP-9 inhibition suppresses wear debris-induced inflammatory osteolysis through downregulation of RANK/RANKL in a murine osteolysis model,” International Journal of Molecular Medicine, vol. 30, no. 6, pp. 1417–1423, 2012. View at Google Scholar
  72. Z. Wang, X. Gao, K. Sun, and Q. Jin, “Experimental study on simvastatin in prevention and treatment of aseptic loosening of prosthesis,” Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, vol. 24, no. 5, pp. 544–547, 2010. View at Google Scholar · View at Scopus
  73. E. M. Schwarz, “WHat potential biologic treatments are available for osteolysis?” The Journal of the American Academy of Orthopaedic Surgeons, vol. 16, pp. S72–S75, 2008. View at Google Scholar · View at Scopus
  74. X. Peng, K. Tao, T. Cheng, J. Zhu, and X. Zhang, “Efficient Inhibition of wear debris-induced inflammation by locally delivered siRNA,” Biochemical and Biophysical Research Communications, vol. 377, no. 2, pp. 532–537, 2008. View at Publisher · View at Google Scholar · View at Scopus
  75. A. Nehme, G. Maalouf, J.-L. Tricoire, G. Giordano, P. Chiron, and J. Puget, “Effect of alendronate on periprosthetic bone loss after cemented primary total hip arthroplasty: A Prospective Randomized Study,” Revue de Chirurgie Orthopedique et Reparatrice de l'Appareil Moteur, vol. 89, no. 7, pp. 593–598, 2003. View at Google Scholar · View at Scopus
  76. T. S. Tapaninen, P. K. Venesmaa, J. S. Jurvelin, H. J. A. Miettinen, and H. P. J. Kröger, “Alendronate reduces periprosthetic bone loss after uncemented primary total hip arthroplasty—a 5-year follow-up of 16 patients,” Scandinavian Journal of Surgery, vol. 99, no. 1, pp. 32–37, 2010. View at Google Scholar · View at Scopus
  77. P. K. Venesmaa, H. P. J. Kröger, H. J. A. Miettinen, J. S. Jurvelin, O. T. Suomalainen, and E. M. Alhava, “Alendronate reduces periprosthetic bone loss after uncemented primary total hip arthroplasty: A Prospective Randomized Study,” Journal of Bone and Mineral Research, vol. 16, no. 11, pp. 2126–2131, 2001. View at Google Scholar · View at Scopus
  78. K. Yamaguchi, K. Masuhara, S. Yamasaki, T. Nakai, and T. Fuji, “Cyclic therapy with etidronate has a therapeutic effect against local osteoporosis after cementless total hip arthroplasty,” Bone, vol. 33, no. 1, pp. 144–149, 2003. View at Publisher · View at Google Scholar · View at Scopus
  79. S. Landgraeber, M. Von Knoch, F. Löer et al., “Association between apoptotis and CD4+/CD8+ T-lymphocyte ratio in aseptic loosening after total hip replacement,” International Journal of Biological Sciences, vol. 5, no. 2, pp. 182–191, 2009. View at Google Scholar · View at Scopus